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Abstract
Background: Allergic sensitization to aeroallergens develops in response to mucosal exposure to these allergens.
Allergic sensitization may lead to the development of asthma, which is characterized by chronic airway
inflammation. The objective of this study is to describe in detail a model of mucosal exposure to cockroach
allergens in the absence of an exogenous adjuvant.
Methods: Cockroach extract (CE) was administered to mice intranasally (i.n.) daily for 5 days, and 5 days later mice
were challenged with CE for 4 consecutive days. A second group received CE i.n. for 3 weeks. Airway
hyperresponsiveness (AHR) was assessed 24 h after the last allergen exposure. Allergic airway inflammation was
assessed by BAL and lung histology 48 h after the last allergen exposure. Antigen-specific antibodies were assessed
in serum. Lungs were excised from mice from measurement of cytokines and chemokines in whole lung lysate.
Results: Mucosal exposure of Balb/c mice to cockroach extract induced airway eosinophilic inflammation, AHR and
cockroach-specific IgG1; however, AHR to methacholine was absent in the long term group. Lung histology
showed patchy, multicentric damage with inflammatory infiltrates at the airways in both groups. Lungs from mice
from the short term group showed increased IL-4, CCL11, CXCL1 and CCL2 protein levels. IL4 and CXCL1 were also
increased in the BAL of cockroach-sensitized mice in the short-term protocol.
Conclusions: Mucosal exposure to cockroach extract in the absence of adjuvant induces allergic airway
sensitization characterized by AHR, the presence of Th2 cytokines in the lung and eosinophils in the airways.
Background
Atopy and allergic diseases affect more than 30% of the
population worldwide. A study in 10 European countries
showed that if we only take into account respiratory
allergic conditions they still have a prevalence between
11.7% and 36.6% [1]. The economic burden of these dis-
eases is also very high [2]. Despite intense efforts over the
last 3 decades, the mechanisms controlling the develop-
ment of allergic sensitization are still poorly understood.
Animal models have been shown to be invaluable in
allowing us to understand the pathogenesis of allergic
conditions, especially asthma.
Animal models of asthma have a number of limitations,
including the physiological relevance of the allergen used
and potential differences between humans and animals in
the development of allergic immune responses. There is
also controversy regarding the utility of murine models
of asthma as predictors of the response of human asthma
to therapeutics [3]. Some of these difficulties arise from
inadequacies of the murine models we use. However,
other differences come from the way we use murine
models and the kinds of responses we expect them to
predict.
These limitations make it imperative that we use more
than one model of asthma to understand specific ques-
tions and that we tailor the model to the question asked.
The development of new murine models, especially of
models that use clinically relevant allergens, may allow us
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using relevant allergens may be proven to be invaluable
for our understanding of the development of allergic sen-
sitization. To this end researchers have developed a num-
ber of different models in mice.
Cockroach allergens are important sensitizing agents
that may contain significant allergenic activity and are an
important cause of asthma exacerbations in many parts
of the World [4]. Several studies indicate that early life
exposure to cockroach allergens leads to the develop-
ment of specific allergic sensitization to cockroaches.
Childhood sensitization has been associated with an
increased risk for persistent asthma and bronchial hyper-
responsiveness and with a greater loss of lung function
[5]. In this regard, a strong relationship between indoor
allergic sensitization and exacerbation of asthma symp-
toms has been demonstrated for cockroach [6]. Although
most of the common cockroach allergens are not serine
proteinases, we inhale these allergens along with a variety
of cockroach-derived proteins with serine proteinase
activity. These cockroach-derived proteins we inhale are
from several sources, including cockroach saliva, feces,
cast skins, debris and dead bodies [7].
Here we present a model that uses a physiological aller-
gen, cockroach allergens present in whole body cockroach
extracts, to cause allergic sensitization, and also a physio-
logical airway mucosal route of sensitization. The objective
of the study was to describe in more detail than what is
available in the literature the characteristics of allergic air-
way inflammation and airway hyperresponsiveness that
develop as a response to mucosal sensitization to cock-
roach allergens.
Methods
Animals
Male BALB/c mice and C57Bl/6 mice (6-8 weeks old)
were purchased from Charles River Laboratories. All mice
were housed in virus- and Ab-free conditions and main-
tained on a 12-h light-dark cycle. All experiments
described in this manuscript were approved by the Univer-
sity of Alberta Health Sciences Laboratory Animal Ethics
Committee (Edmonton, AB, Canada).
Intranasal administration of whole cockroach extract (CE)
Lyophilized frozen whole body extracts from German
cockroach (Blattella germanica) were obtained from Greer
Laboratories, (Lenoir, NC, USA) and were resuspended in
sterile normal saline and stored at 4°C. Following light
anesthesia with ketamine (75 mg/kg) and acepromazine
(2.5 mg/kg), mice were given 50 μg of whole cockroach
extract dissolved in 25 μl of sterile normal saline intrana-
sally (i.n.) using the short-term and long term protocols
s h o w ni nF i g u r e1 A .C o n t r o lm i c ew e r eg i v e n2 5μlo f
sterile normal saline at the same time points. Other mice
were sensitized with an i.p. injection of 50 μg of CE and 4
mg of Al(OH)3 in 0.5 ml of 0.9% sterile saline and then
challenged with CE i.n., as shown in Figure 1A. In this
case an i.p. injection of 0.5 ml of 0.9% sterile saline solu-
tion without CE was used as a negative control.
Evaluation of AHR and allergic airway inflammation
Twenty-four hours after the final i.n. CE administration,
we measured enhanced pause (Penh) to increasing doses
of methacholine by non-invasive whole-body plethysmo-
graphy (Buxco Electronics, Wilmington, NC, USA) to
determine AHR as described [8]. Mice were euthanized 48
h after the last challenge for blood collection by cardiac
puncture and lung lavage. The lungs were lavaged five
times with 1 ml of isotonic phosphate-buffered saline pH
7.4 and 5 ml of this bronchoalveolar lavage (BAL) fluid
was collected. Lungs were then removed and kept frozen
until being processed for protein analysis. Protein analysis
of lung lysates and BAL fluid was performed by Eve Tech-
nologies Corporation (Calgary, Canada) using a multiplex
assay based on color-coded polystyrene beads.
The BAL fluid was centrifuged at 300 g for 5 min. Total
cells were counted and then cytospins of 5000 cells were
prepared and stained with Diff-Quick (Fisher Scientific
Co, Kalamazoo, MI, USA). Airway inflammation was
assessed by counting the number of inflammatory cells in
the BAL fluid as previously described [9]. The cellular
composition of bronchoalveolar lavage fluid was also
assessed by FACS analysis. BAL cells were stained with
anti-CD3, CD11c, CD19, MHCII, and CCR3 antibodies
(BD Pharmingen, San Diego, CA). Data were acquired
using a FACS Canto (Becton Dickinson, Oakville, Canada)
a n da n a l y z e du s i n gF l o w J os o ftware (TreeStar, Ashland,
OR). Lymphocytes were identified as Forward Scatter low/
Side Scatter low cells expressing CD3 (T cells) or CD19 (B
cells). Granulocytes were recognized as Side Scatter high
cells and eosinophils were defined as Side Scatter high
cells that express the eotaxin receptor CCR3 and inter-
mediate levels of CD11c but very low to undetectable
levels of MHCII, CD19 and CD3. Neutrophils were
detected in a similar scatter profile as eosinophils but
lacked CCR3 expression. Dendritic cells were identified as
CD3
-CD19
- cells that express high levels of MHCII and
CD11c.
Detection of cockroach specific IgG1 and IgG2a
Cockroach-specific IgG1 and IgG2a in mouse serum
were measured by ELISA. Briefly, CE was incubated over-
night at 4°C in 96-well NUNC MaxiSorp plates (Corning
Costar Corp. NY, USA). Plates were then washed and
blocked with PBS/10% FBS (GIBCO Invitrogen, Grand
Islands, NY, USA), and mouse sera was added, and incu-
bated for 3 h at 24°C. A 1:5,000 dilution of Biotin Rat
anti-mouse-IgG1 (BD Pharmingen, Mississauga, ON,
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Figure 1 Sensitization of Balb/c mice to CE allergens. A. Models of mucosal and intraperitoneal sensitization to CE. B. AHR (Penh) was assessed
24 h after the last challenge for mice sensitized using the short-term (saline-saline n = 5; saline-CE n = 5; CE-CE n = 5; left graph) long-term (saline-
saline n = 6; CE-CE n = 13; middle graph) and intraperitoneal (saline-saline n = 5; CE-CE n = 8; right graph) models. Allergic airway inflammation
was measured 24 h after AHR by assessing the total cell numbers in the BAL fluid for the (C) short-term (saline-saline n = 8; saline-CE n = 8; CE-CE n
= 8), long-term (saline-saline n = 6; CE-CE n = 14) and intraperitoneal models (saline-saline n = 7; CE-CE n = 7) as well as total eosinophils in the
BAL fluid (D) for the short term (saline-saline n = 8; saline-CE n = 8; CE-CE n = 8), long-term (saline-saline n = 6; CE-CE n = 14) and intraperitoneal
models (saline-saline n = 7; CE-CE n = 7). The serum from these mice was analyzed using ELISA for the presence of cockroach-specific IgG1
antibodies (E) and cockroach-specific IgG2a antibodies (F) for the short term (saline-saline n = 3; saline-CE n = 5; CE-CE n = 3), long-term (saline-
saline n = 5; CE-CE n = 12) and intraperitoneal models (saline-saline n = 7; CE-CE n = 7). Values shown in B-F are means ± SEM.
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gen) in PBS/10% FBS was added and plates were incu-
bated for 1 h at 24°C, followed by the addition of a
1:1000 dilution (in PBS/10% FBS) of Horseradish peroxi-
dase-conjugated streptavidin (Jackson ImmunoResearch
Laboratories, Inc., Burlington, ON, Canada). TMB (BD
Pharmingen) was added as a substrate, and allowed 20
min at 24°C to develop. The reaction was stopped by the
addition of 2 N H2SO4, and the absorbance was mea-
sured at 405 nm on a Power Wave XS (BioTek Instru-
ments Inc., Winooski, VT, USA) ELISA reader. Results
are shown as absorbance units.
Histological analysis
Animals were euthanized and the trachea intubated with a
polyethylene catheter. Lungs were inflated with 10% neu-
tral buffered formalin (Sigma-Aldrich, St. Louis MO, USA)
for 10 min at a constant pressure of 20 cm water and then
removed from the animal and placed in fresh 10% neutral
buffered formalin for 24 h at 4°C before embedding in par-
affin blocks. Sections (4 μm) were stained with H&E and
PAS-D and analyzed using a Nikon Eclipse E-600 Micro-
scope with 2X, 10X, 20X and 40X objectives. Pictures
were taken using an 11-megapixel DXM 1200C Nikon
Digital Camera.
Statistical analysis
Values are expressed as “mean ± S.E.M”. Statistical differ-
ences in the mean values among treatment groups were
determined using a paired Student t test. In all cases, a
value for p < 0.05 was considered statistically significant.
Results
We have developed a model for mucosal sensitization of
mice using whole body cockroach extract. Groups of mice
received 50 μg of CE intranasally after anesthesia on 5
consecutive days, rested for 5 days and then received
50 μg of CE intranasally daily for 4 more days. Airway
hyperresponsiveness (AHR) was assessed 24 h after the
last allergen exposure and allergic airway inflammation
was assessed 48 h after the last allergen exposure using
BAL and lung histology (Figure 1A - short term protocol).
To extend the duration of exposure to allergen we sensi-
tized another group of mice with 50 μg of CE intranasally
5 days a week for 3 weeks, and for 2 consecutive days on
the fourth week before evaluation for AHR and allergic
airway inflammation as before (Figure 1A - long term pro-
tocol). Control groups of mice received saline on the same
schedule. To compare our models with better-established
models of parenteral sensitization in the presence of an
adjuvant, a group of mice were sensitized with CE extract
and Al(OH)3 i.p. and then challenged with CE i.n. (Figure
1A - i.p.).
Mice sensitized and challenged with CE using the short
term protocol developed AHR (Figure 1B) and increased
numbers of inflammatory cells (Figure 1C), primarily
eosinophils (Figure 1D), in the airways, compared to
mice who received saline only. FACS analysis also
revealed an increase in T and B lymphocytes in mice that
received CE in the short term protocol compared to mice
that received saline, but no differences in the numbers of
dendritic cells and neutrophils (Figure 2). Total lympho-
cytes in the BAL also increased in the mice that received
CE in the long term protocol (from 416 ± 126 cells per
mouse in mice receiving saline to 1807 ± 320 cells per
mouse in mice receiving CE, n = 9, p < 0.02), but CE
again had no effect on neutrophil numbers. Mice exposed
to CE in the long term protocol showed less pronounced
allergic responses. There was no evidence of AHR in the
long term protocol and the numbers of eosinophils were
diminished compared to the short term protocol (Figure
1). In both the short and long term protocols allergic air-
way inflammation was lower than what was seen with i.p.
sensitization to CE in the presence of Al(OH)3 (Figure
1C and 1D).
We also evaluated the presence of antigen-specific
antibodies. Mice receiving CE developed cockroach-spe-
cific IgG1 (Figure 1E), the levels of which were not dif-
ferent between the short term, long term and i.p.
models. Mice that underwent the short term and long
term protocols had no evidence of increased cockroach-
specific IgG2a, while mice undergoing the i.p. protocol
did develop antigen-specific IgG2a (Figure 1F).
We performed histological analysis of lungs from mice
sensitized and challenged with CE using both the short-
term and the long-term models (Figure 3). Hematoxylin
and eosin (H&E) stained sections showed normal lung
architecture without inflammation in the airways or
interstitium of mice sensitized with saline in the short-
term (Figure 3A) and long-term (Figure 3C) models.
Histological sections from mice sensitized and chal-
lenged with CE in the short-term model showed lung
parenchyma with rare foci of inflammation, which in
the case shown is partially destroying a small airway.
Surrounding alveolar parenchyma was generally normal
(Figure 3B). Mice sensitized and challenged with CE in
the long-term model showed patchy, perivascular
inflammation without large aggregates of inflammatory
cells and mild edema (Figure 3D). Airways and sur-
rounding alveolar parenchyma were largely normal. PAS
with diastase (PAS-D) stained sections from mice sensi-
tized and challenged with saline showed no evidence of
mucin-containing epithelial cells in the airways (PAS-D
negative sections) (Figure 3E and 3G). PAS-D stained
sections from short-term (Figure 3F) and long-term
(Figure 3H) CE sensitized mice showed numerous
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airways.
We also sensitized C57Bl/6 mice using the short term
protocol. Because we detected a large difference between
mice receiving saline in the sensitization phase and CE
in the challenge phase vs. mice receiving CE in both
phases in Balb/c mice, we used only these two groups
for the C57Bl/6 experiments. Mice that received CE in
both phases showed increased total cells (Figure 4A)
and eosinophils (Figure 4B) in BAL fluid, and increased
cockroach-specific IgG1 (Figure 4C) compared to mice
that received saline during the sensitization phase and
CE during the challenge phase. These mice also showed
evidence of AHR (data not shown). This indicates that
the cockroach extract has similar effects in Balb/c and
C57Bl/6 mice and that both strains can be sensitized to
CE intranasally.
We then studied the presence of cytokines and chemo-
kines in the lung tissue and airways of cockroach-sensi-
tized and challenged mice. Lungs were removed from
mice undergoing the short term protocol and then lyzed
to measure cytokines and chemokines using a multiplex
assay based on color-coded polystyrene beads. IL-4,
CCL11 (eotaxin), CXCL1 (KC) and CCL2 (MCP-1) were
increased in the lungs of sensitized and challenged mice
(Figure 5). An increase in IL-4 and CXCL1 was also seen
in the BAL fluid of these mice, but CCL11 and CCL2
were not increased in the BAL fluid (Figure 5). In all
cases there were significantly lower levels of the cytokines
in the BAL fluid compared to the lung lysate. In general
Figure 2 Numbers of T lymphocytes, B lymphocytes, dendritic cells and neutrophils in the BAL fluid of mice sensitized and
challenged with cockroach allergens using the short term protocol. BAL fluid from cockroach sensitized and challenged mice and mice
receiving only saline were analyzed by flow cytometry as described in Methods Section (n = 5 per group, * = p < 0.01).
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most of the cytokines and chemokines analyzed in BAL
fluid and for most of those that could be measured in the
BAL fluid there was no difference between naïve and
allergen sensitized and challenged mice (data not shown).
A number of other cytokines/chemokines were also
significantly increased in t h el u n gt i s s u eo fm i c et h a t
were sensitized and challenged with CE. IL-5 and IL-13
were increased, as expected, but IL-12p40, GM-CSF,
CCL3 (MIP-1a), CCL4 (MIP-1b) were also increased
( d a t an o ts h o w n ) .A l s oG - C S F ,I L - 1 7 A ,C X C L 9( M I G ) ,
and CXCL10 (IP10) were elevated in the lung tissue
(Figure 6). G-CSF and IL-17A were also increased in the
BAL fluid of these mice (although the levels were signif-
icantly lower than the levels in the lung tissue), but
CXCL9 and CXCL10 were not increased in the BAL
fluid (Figure 6). However, IL-10, IFNg,R A N T E Sa n d
VEGF were not increased following sensitization and
challenge with CE.
Discussion
In this manuscript we present a detailed analysis of the
airway inflammation present in a model of mucosal sen-
sitization to cockroach allergens. Mice sensitized to cock-
roach through the intranasal route in the absence of an
adjuvant developed all the expected characteristics of
asthma; they developed AHR, eosinophilic airway inflam-
mation and allergen-specific IgG1 antibodies after expo-
sure to allergens over a period of 2 weeks. These mice
also showed increased levels of Th2 cytokines and a
number of chemokines in the lung tissue. Mucosal expo-
sure to CE led to allergic inflammation in both Balb/c
and C57Bl/6 mice, although the latter had lower numbers
of eosinophils accumulating in the airways. Mice exposed
to CE for longer periods, 17 intranasal exposures over
31/2 weeks, showed lower AHR and less eosinophils in
the BAL compared to mice treated with the short term
model. Histological evaluation of the short and long term
models showed changes compat i b l ew i t ha l l e r g i ca i r w a y
inflammation. The changes seen in the lungs stained with
H&E were quite mild compared to other murine models
of asthma. CE induced inflammation in both the short
and long term models compared to non-sensitized mice.
The inflammation seen in the long term model was more
diffuse with smaller aggregates of inflammatory cells than
what was seen in the short term model. PAS-D staining
of the lungs of CE sensitized and challenged mice showed
increased goblet cells in the airways in both models com-
pared to non-sensitized mice. The exact reason for
decreased levels of inflammation in the long term proto-
col are not known. Other groups using various models
have shown that longer exposure to allergens can lead to
tolerance and therefore have decreased levels of inflam-
mation compared to the allergic inflammation seen fol-
lowing shorter exposure periods [10,11]. It is possible
that a similar effect is seen in our model.
Allergic sensitization to cockroach allergens has been
associated with severity of asthma in inner cities of USA.
Animal models using these allergens may allow us to bet-
ter understand the role of these antigens in allergy and
asthma. Cockroach allergens have been used previously
in murine models of allergic sensitization [12-14], but
those studies used an intraperitoneal injection of cock-
roach in the presence of an adjuvant to sensitize mice.
Recently our laboratory [15] and others [16,17] have
developed models of mucosal sensitization to cockroach
Figure 3 Histological analysis of mice sensitized to cockroach allergens. Representative pictures from mice sensitized under the short term
protocol (A, B, E and F) and long-term protocol (C, D, G and H) are shown. A-D H&E for mice sensitized and challenged with saline (A and C) or
CE (B and D). E-G PAS-D staining for mice sensitized and challenged with saline (E and G) or CE (F and H).
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Page 6 of 10Figure 4 Sensitization of C57Bl/6 mice to CE allergens. AHR (Penh) was assessed 24 h after the last challenge (A) (saline-CE n = 12; CE-CE n
= 16). Allergic airway inflammation was assessed 24 h after AHR using total cell numbers (B) and total eosinophils (C) present in BAL fluid
(saline-CE n = 12; CE-CE n = 16). The serum from these mice was analyzed using ELISA for the presence of cockroach-specific IgG1 antibodies
(D) (saline-CE n = 3; CE-CE n = 3). Values shown are means ± SEM.
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using house dust mite allergens. Our model presented
here and in our previous work [15] differs from that used
by Page and colleagues [16,17] because we used whole
cockroach body extract, rather than cockroach frass, to
induce allergic sensitization. However, the two models
have many similarities. Our aim here was to describe this
model in more detail and analyze various aspects of the
inflammatory environment induced by mucosal sensitiza-
tion to cockroach allergens.
Our data indicate that i.n. sensitization generates a
more Th2-like IgG response (increased antigen-specific
I g G 1 ,b u tn o tI g G 2 a )c o m p a r e dt om u r i n em o d e l st h a t
use i.p. sensitization (both IgG subtypes were increased).
In accordance with our data, Phipps et al., were unable to
detect allergen-specific IgG2a in i.n. sensitized mice [18],
while Ng et al., only detected allergen-specific-IgG2a in
the serum of mice when an allergen was given i.n. with a
strong Th1 polarizing stimulus [19]. These data indicate
that mucosal sensitization to cockroach extract leads to a
more Th2 skewed model of airway inflammation com-
pared to mice sensitized intraperitoneally in the presence
of an adjuvant. Our model therefore, induced a strong
allergic phenotype, which supports the validity and value
of this model to study mechanisms of allergic
sensitization.
We also analyzed the cytokines and chemokines pre-
sent in the lungs of mice sensitized and challenged with
our short term protocol. We identified increased levels of
Th2 cytokines (IL-4, IL-5 and IL-13) as would be
expected, as well as increased levels of IL-17A and G-
CSF. Increases in IL-17A and G-CSF have been shown
previously in a slightly different model of sensitization to
cockroach allergens, although in that case the increase
was seen in cultured lung cells stimulated with conA
[16,17].
We also identified the presence of CXCL1 (KC) in the
lungs of cockroach-sensitized and challenged mice.
CXCL1 (KC) is a chemotactic factor for neutrophils. Our
model does not have a high number of neutrophils
recruited to the lung. However, it has been shown in a
model of OVA-induced allergic airway inflammation that
CXCL1 (KC) also recruits endothelial progenitors to the
lung [20]. The same molecule has been shown to be
Figure 5 Cytokines and chemokines in lung tissue and BAL fluid of cockroach-sensitized and challenged mice. Levels of IL-4, CCL11
(eotaxin), CXCL1 (KC) and CCL2 (MCP-1) in lung lysates (upper panels) and BAL (lower panels) from mice challenged with saline or CE (n = 5, *p
< 0.05).
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challenge and correlates with endothelial progenitor
recruitment in the airways [21]. Furthermore, a molecular
phenotype characterized by the presence of CXCL1,
RANTES, IFNg, IL-12 and IL-10 separated children with
severe asthma from those with moderate asthma [22].
Further work on the presence and role of CXCL1 (KC) in
murine models of allergic inflammation may allow us to
better understand the pathogenesis of disease and vascular
remodeling during asthma.
Cockroach is a complex mix of many proteins includ-
ing serine proteinases. A number of common environ-
mental allergens, including cockroach allergens, have
enzymatic activity, which may skew the immune response
toward the Th2 phenotype [23] and mediate, or at least
participate in, the development of allergic sensitization.
We have published evidence that the serine proteinase
activity of cockroach allergens and their ability to activate
Proteinase-Activated Receptor-2 (PAR-2) may be an
important determinant of the ability to induce allergic
sensitization [15]. Developing a model of allergic sensiti-
zation using cockroach extract will allow us to dissect the
complexity of the extract and to identify the ability of
individual antigens to induce allergic sensitization or to
function as effective allergens. For example, one cock-
roach allergen, Per a 10, has been cloned and its proteo-
lytic activity has been shown to be important for the
development of allergic inflammation and AHR [24].
Availability of many different models of mucosal sensiti-
zation to be used in comparative studies may also allow
us to better understand the basic mechanisms that parti-
cipate in allergic sensitization and allergic airway inflam-
mation. There is already evidence that different allergens
induce different activation pathways in the airways in
murine models [25] and comparing more models may
expand our knowledge in this field.
These studies also allow us to better understand the
regulation of the mucosal immune system in the lung.
Mucosal immunology has been, for decades, an area of
study in gastrointestinal diseases and has allowed an
understanding of many facets of the immune system
[26,27]. Translation of these studies into the airways will
allow us to obtain a similar understanding of the airway
mucosal immune responses.
Figure 6 G-CSF, IL-17A, CXCL9 and CXCL10 levels in lung tissue and BAL fluid of cockroach-sensitized and challenged mice. Levels of
these cytokines and chemokines in lung lysates (upper panels) and BAL (lower panels) from mice challenged with saline or CE (n = 5, *p < 0.05).
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In conclusion, we have presented a detailed analysis of a
model of allergic sensitization using mucosal exposure
to cockroach allergens, which is functional in both Balb/
c and C57Bl/6 mice. This model may allow us to better
understand the role of cockroach allergens in allergic
disease and in the inner city asthma epidemic.
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